Paul Cloos

Paul Cloos is a scientist with expertise in cancer, epigenetics, protein chemistry, molecular cell biology, and transgene techniques. They hold a PhD in Medicine from the University of Copenhagen and have over 15 years of project management experience within diagnostic development, target discovery, drug screening, and drug development. Paul has authored or co-authored more than 30 peer-reviewed scientific papers and is an inventor or co-inventor of over 10 patent families. They co-founded Epitherapeutics, which focuses on developing novel cancer therapies and has secured over 20 million € in investments. Currently, Paul serves as the Head of BiOrigin Laboratory and the Chief Executive Officer of Biohagen Labs.